Search research articles
Contact Us
Filters
Showing results (121-130 of 189) with videos related to
Page
of 19
Sort By:
British Journal of Haematology
|
September 30, 1998
Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease
R F Franco, M A Zago, M D Trip, et al.
Thrombosis Research
|
December 6, 2022
Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism
A F J Iding, B M M Kremers, M Nagy, et al.
British Journal of Haematology
|
July 1, 1995
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?
H J Wolters, H ten Cate, L L Thomas, et al.
The Lancet. Infectious Diseases
|
December 31, 2002
Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence
A T A Mairuhu, M R Mac Gillavry, T E Setiati, et al.
The Netherlands Journal of Medicine
|
May 5, 2005
Is chronic HIV infection associated with venous thrombotic disease? A systematic review
S K Klein, E J Slim, M D de Kruif, et al.
European Journal of Internal Medicine
|
July 7, 2010
Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism
M M J Beckers, H J T Ruven, F J L M Haas, et al.
Blood
|
October 27, 1998
Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia
M C Minnema, D Pajkrt, W A Wuillemin, et al.
Scandinavian Journal of Immunology
|
January 1, 1996
Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6
T van der Poll, J Jansen, M Levi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 2000
Activation of clotting factors XI and IX in patients with acute myocardial infarction
M C Minnema, R J Peters, R de Winter, et al.
American Journal of Hematology
|
September 11, 2002
No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease
J B Schnog, M R Mac Gillavry, R A Rojer, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 189) with videos related to
Sort By:
Page
of 19
British Journal of Haematology
|
September 30, 1998
Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease
R F Franco, M A Zago, M D Trip, et al.
Thrombosis Research
|
December 6, 2022
Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism
A F J Iding, B M M Kremers, M Nagy, et al.
British Journal of Haematology
|
July 1, 1995
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?
H J Wolters, H ten Cate, L L Thomas, et al.
The Lancet. Infectious Diseases
|
December 31, 2002
Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence
A T A Mairuhu, M R Mac Gillavry, T E Setiati, et al.
The Netherlands Journal of Medicine
|
May 5, 2005
Is chronic HIV infection associated with venous thrombotic disease? A systematic review
S K Klein, E J Slim, M D de Kruif, et al.
European Journal of Internal Medicine
|
July 7, 2010
Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism
M M J Beckers, H J T Ruven, F J L M Haas, et al.
Blood
|
October 27, 1998
Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia
M C Minnema, D Pajkrt, W A Wuillemin, et al.
Scandinavian Journal of Immunology
|
January 1, 1996
Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6
T van der Poll, J Jansen, M Levi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 2000
Activation of clotting factors XI and IX in patients with acute myocardial infarction
M C Minnema, R J Peters, R de Winter, et al.
American Journal of Hematology
|
September 11, 2002
No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease
J B Schnog, M R Mac Gillavry, R A Rojer, et al.
Page
of 19